GlassScriptPhysician profile
Paul Arnold
NPI 1841294501
$54,527.00
in general payments reported to CMS, 2019-2025
57 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $8,650 · 2021: $3,564 · 2022: $3,188 · 2023: $2,428 · 2024: $2,582 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $4,395 · Travel and Lodging: $2,250 · Honoraria: $150 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,752.50 |
| Consulting Fee | $4,395.32 |
| Travel and Lodging | $2,250.29 |
| Honoraria | $150.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25,964.73 | 2019-2025 | Rezum Generator, Ams 700, Lithovue |
| Axonics, INC. | $5,703.31 | 2020-2024 | Axonics, Bulkamid |
| Richard Wolf Medical Instruments Corp. | $5,156.77 | 2023-2025 | |
| Srs Medical Systems, INC. | $3,053.55 | 2019-2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Gyrus Acmi, INC. | $1,815.00 | 2020 | |
| Verathon INC. | $1,500.00 | 2025 | Npd Clinical Study |
| Coloplast Corp | $1,307.23 | 2019-2025 | |
| Olympus America INC. | $932.67 | 2022-2025 | Itind System, Hd Camera Head, Gyrus Acmi |
| Procept Biorobotics Corporation | $909.59 | 2019-2025 | Aquabeam Robotic System, Aquabeam System |
| Medtronic, INC. | $744.73 | 2021-2025 | Interstim |
| Dendreon Pharmaceuticals LLC | $617.42 | 2019-2025 | Provenge |
| Baxter Healthcare | $548.06 | 2024-2025 | Tisseel |
| Astellas Pharma US INC | $441.96 | 2019-2023 | Xtandi |
| Endo USA, INC. | $411.94 | 2024-2025 | Xiaflex, Aveed, Edex |
| Ethicon US, LLC | $410.48 | 2024-2025 | Vistaseal, Surgicel Nu-Knit, Evarrest |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $374.95 | 2021-2025 | Jelmyto |
| Ambu INC. | $360.02 | 2020-2025 | |
| Endo Pharmaceuticals INC. | $269.48 | 2020-2024 | Xiaflex, Aveed, Edex |
| Karl Storz Endoscopy-America | $264.82 | 2023-2025 | Image1 Connect, N.A., Hopkins |
| Edap Technomed INC | $238.54 | 2024-2025 | |
| Dornier Medtech America, INC | $226.24 | 2019-2025 | Dornier Medtech |
| Stryker Corporation | $222.89 | 2021-2025 | 1788 |
| Pfizer INC. | $220.86 | 2019-2023 | |
| Abbvie INC. | $215.90 | 2019-2020 | |
| Intuitive Surgical, INC. | $212.66 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $204.84 | 2024-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $203.81 | 2019-2024 | Erleada, Akeega |
| Neotract INC. | $188.89 | 2019 | |
| Laborie Medical Technologies Corp. | $180.31 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Teleflex LLC | $159.44 | 2024 | Urolift |
| Valencia Technologies Corporation | $153.12 | 2023-2025 | Ecoin Device Kit |
| Penumbra, INC. | $142.34 | 2025 | Indigo System |
| Ferring Pharmaceuticals INC. | $140.08 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $128.12 | 2019 | |
| Urogpo LLC | $124.23 | 2019 | |
| United Medical Systems (De), INC. | $111.66 | 2020-2024 | |
| Profound Medical Corp. | $89.01 | 2023-2025 | Tulsa-Pro |
| Novartis Pharmaceuticals Corporation | $64.58 | 2023-2025 | |
| Tolmar Pharmaceuticals, INC. | $59.09 | 2019 | |
| Verity Pharmaceuticals INC. | $54.31 | 2022-2024 | Trelstar |
| Medtronic USA, INC. | $48.57 | 2019-2020 | |
| Angiodynamics, INC. | $47.49 | 2023 | Nanoknife |
| Blue Earth Diagnostics | $44.02 | 2019 | |
| Myriad Genetic Laboratories, INC. | $38.89 | 2022 | |
| 180 Medical, INC. | $29.96 | 2024 | |
| Smith+Nephew, INC. | $28.66 | 2025 | Grafix Pl |
| Integra Lifesciences Corporation | $24.48 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Therapeuticsmd, INC. | $23.20 | 2019 | |
| Tela Bio, INC. | $19.68 | 2021 | |
| Amgen INC. | $16.63 | 2019 | |
| Acerus Pharmaceuticals Corporation | $15.77 | 2020 | |
| Amniox Medical, INC. | $14.66 | 2019 | |
| Allergan, INC. | $12.95 | 2019 | |
| Antares Pharma, INC. | $12.21 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $11.23 | 2020 | |
| Kerecis Limited | $10.97 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$66,817.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.